Anglicheau D - Search Results

1

Isolated v-lesion in kidney transplant recipients: Characteristics, association with DSA, and histological follow-up.

Rabant M, Boullenger F, Gnemmi V, Pellé G, Glowacki F, Hertig A, Brocheriou I, Suberbielle C, Taupin JL, Anglicheau D, Legendre C, Duong Van Huyen JP, Buob D. Rabant M, et al. Among authors: anglicheau d. Am J Transplant. 2018 Apr;18(4):972-981. doi: 10.1111/ajt.14617. Epub 2018 Jan 12. Am J Transplant. 2018. PMID: 29206350 Free article.

2

Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients.

Thervet E, Anglicheau D, Toledano N, Houllier AM, Noel LH, Kreis H, Beaune P, Legendre C. Thervet E, et al. Among authors: anglicheau d. J Am Soc Nephrol. 2001 Jan;12(1):170-176. doi: 10.1681/ASN.V121170. J Am Soc Nephrol. 2001. PMID: 11134264

3

Clinical consequences of the polymorphism of azathioprine metabolism.

Thervet E, Anglicheau D, Toledano N, Kreis H, Legendre C, Beaune P. Thervet E, et al. Among authors: anglicheau d. Transplant Proc. 2000 Dec;32(8):2780. doi: 10.1016/s0041-1345(00)01882-0. Transplant Proc. 2000. PMID: 11134802 No abstract available.

4

Recent issues concerning renal transplantation in systemic lupus erythematosus patients.

Thervet E, Anglicheau D, Legendre C. Thervet E, et al. Among authors: anglicheau d. Nephrol Dial Transplant. 2001 Jan;16(1):12-4. doi: 10.1093/ndt/16.1.12. Nephrol Dial Transplant. 2001. PMID: 11208985 Review. No abstract available.

5

[Pharmacology of mycophenolate mofetil: recent data and clinical consequences].

Thervet E, Anglicheau D, Legendre C. Thervet E, et al. Among authors: anglicheau d. Nephrologie. 2001;22(7):331-7. Nephrologie. 2001. PMID: 11817210 Review. French.

6

Long-term renal allograft outcome after simultaneous kidney and pancreas transplantation.

Rerolle JP, Thervet E, Anglicheau D, Desgrandchamps F, Nochy D, Janin A, Fornairon S, Passa P, Bedrossian J, Legendre C. Rerolle JP, et al. Among authors: anglicheau d. Nephrol Dial Transplant. 2002 May;17(5):905-9. doi: 10.1093/ndt/17.5.905. Nephrol Dial Transplant. 2002. PMID: 11981082

7

Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis.

Anglicheau D, Lautrette A, Scieux C, Thervet E, Martinez F, Flamant M, Morinet F, Legendre C. Anglicheau D, et al. Transplant Proc. 2002 Nov;34(7):2826-7. doi: 10.1016/s0041-1345(02)03531-5. Transplant Proc. 2002. PMID: 12431624 No abstract available.

8

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.

Anglicheau D, Verstuyft C, Laurent-Puig P, Becquemont L, Schlageter MH, Cassinat B, Beaune P, Legendre C, Thervet E. Anglicheau D, et al. J Am Soc Nephrol. 2003 Jul;14(7):1889-96. doi: 10.1097/01.asn.0000073901.94759.36. J Am Soc Nephrol. 2003. PMID: 12819250

9

Efficacy and safety of lowering immunosuppression to treat CMV infection in renal transplant recipients on valaciclovir prophylaxis: a pilot study.

Anglicheau D, Lautrette A, Scieux C, Flamant M, Morinet F, Legendre C. Anglicheau D, et al. Nephrol Dial Transplant. 2003 Aug;18(8):1654-6. doi: 10.1093/ndt/gfg251. Nephrol Dial Transplant. 2003. PMID: 12897109

10

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.

Anglicheau D, Flamant M, Schlageter MH, Martinez F, Cassinat B, Beaune P, Legendre C, Thervet E. Anglicheau D, et al. Nephrol Dial Transplant. 2003 Nov;18(11):2409-14. doi: 10.1093/ndt/gfg381. Nephrol Dial Transplant. 2003. PMID: 14551375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters